tiprankstipranks
Trending News
More News >
ENDRA Life Sciences Inc (NDRA)
NASDAQ:NDRA
US Market

ENDRA Life Sciences (NDRA) Financial Statements

Compare
801 Followers

ENDRA Life Sciences Financial Overview

ENDRA Life Sciences's market cap is currently $2.50M. The company's EPS TTM is $-1.86; its P/E ratio is ―; ENDRA Life Sciences is scheduled to report earnings on May 15, 2025, and the estimated EPS forecast is $-2.27. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ -275.45K$ -234.26K$ -224.41K$ -165.25K
Operating Income$ -18.14M$ -10.52M$ -13.16M$ -11.50M$ -11.50M
EBITDA$ -11.30M$ -10.40M$ -12.94M$ -11.01M$ -11.33M
Net Income$ -11.51M$ -10.06M$ -13.20M$ -11.19M$ -11.97M
Balance Sheet
Cash & Short-Term Investments$ 3.23M$ 2.83M$ 4.89M$ 9.46M$ 7.23M
Total Assets$ 4.45M$ 6.75M$ 9.27M$ 12.87M$ 8.76M
Total Debt$ 584.42K$ 394.40K$ 546.63K$ 678.96K$ 685.47K
Net Debt$ -2.65M$ -2.44M$ -4.34M$ -8.78M$ -6.54M
Total Liabilities$ 1.89M$ 1.10M$ 2.07M$ 2.09M$ 1.60M
Stockholders' Equity$ 2.56M$ 5.66M$ 7.20M$ 10.78M$ 7.17M
Cash Flow
Free Cash Flow$ -7.42M$ -9.58M$ -12.97M$ -11.17M$ -10.82M
Operating Cash Flow$ -7.40M$ -9.55M$ -12.77M$ -11.12M$ -10.77M
Investing Cash Flow$ -12.80K$ -24.72K$ -202.58K$ -45.00K$ -51.33K
Financing Cash Flow$ 7.81M$ 7.52M$ 8.40M$ 13.40M$ 11.88M
Currency in USD

ENDRA Life Sciences Earnings and Revenue History

ENDRA Life Sciences Debt to Assets

ENDRA Life Sciences Cash Flow

ENDRA Life Sciences Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis